NRX Pharmaceuticals, Inc.

Big Rock Partners Acquisition Corp (NASDAQ: BRPA), sponsored by Big Rock Partners LLC, was a blank-check company that completed its IPO in 2019 with a focus on the healthcare and life sciences sector. In March 2021, BRPA announced a definitive merger agreement with NRX Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders and critical pulmonary conditions. The transaction subsequently closed, with the combined company operating in the biotech and pharma space under the NRX Pharmaceuticals name. The deal is now recorded as closed. Visit SpacDesk and sign up for full data, deal timelines, and analytics on this transaction and hundreds of others.

SPAC Counterparty (1)